Results 101 to 110 of about 8,542 (116)

Ulcère de Marjolin chez une femme de 63 ans aux prises avec une hidrosadénite suppurée. [PDF]

CMAJ
Kanou M, Alamari A, Litvinov IV.
europepmc   +1 more source

Les agonistes du récepteur du peptide-1 de type glucagon pour traiter la néphropathie chronique associée à un diabète de type 2. [PDF]

CMAJ
Khan I, Lanktree MB.
europepmc   +1 more source

Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets - a SwissDiab study. [PDF]

Front Endocrinol (Lausanne)
Liu C, Renström F, Gastaldi G, Brändle M, Bilz S.   +4 more
europepmc   +1 more source

Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the 'TreC Diabete' platform (TELEMECHRON Study). [PDF]

Front Clin Diabetes Healthc
Giovanazzi A, Gios L, Gentilini MA, Mastellaro M, Bartolotta P, Nicolussi Giacomaz L, Eccher C, Inchiostro S.   +7 more
europepmc   +1 more source

Design and prioritization of the French surveillance program of health effects in the context of exposure to endocrine disruptors using a Delphi study. [PDF]

BMC Public Health
Peyronnet A, Le Barbier M, Morel P, Naud J, Menard C, Caudeville J.   +5 more
europepmc   +1 more source

Diabète de type 2 à début précoce. [PDF]

CMAJ
Kanagalingam T, Yu C, Ke C.
europepmc   +1 more source

Does Ongoing Inflammation in Recovered COVID-19 Disease Aggravates Preexistent Diabetes Mellitus or Unmasks New-onset Diabetes Mellitus? A Single-center Experience of 800 Cases at 6-month Follow-up.

Ann Afr Med
Patil S, Kulkarni D, Gondhali G.
europepmc   +1 more source

A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events. [PDF]

Diabetes Obes Metab
Riveline JP, Julla JB, Bonnemaison E, Joubert M, Lablanche S, Gazagnes AS, Demarsy D, Gouet D, Schaepelynck P, Amouyal C, Vale FD, Schletzer-Mari A, Clavel S, Spiteri A, Campinos C, Favre S, Tauveron I, Mathivon L, Borot S, Fagherazzi G, Breton MD, Gautier JF, Renard E, OB2F study group.   +23 more
europepmc   +1 more source